Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
216.13
+1.31 (0.61%)
At close: May 1, 2024, 4:00 PM
217.50
+1.37 (0.63%)
After-hours: May 1, 2024, 6:45 PM EDT
Biogen Revenue
Biogen had revenue of $9.66B in the twelve months ending March 31, 2024, down -4.37% year-over-year. Revenue in the quarter ending March 31, 2024 was $2.29B, a -7.00% decrease year-over-year. In the year 2023, Biogen had annual revenue of $9.84B, a decrease of -3.32%.
Revenue (ttm)
$9.66B
Revenue Growth
-4.37%
P/S Ratio
3.26
Revenue / Employee
$1,276,499
Employees
7,570
Market Cap
31.47B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
Dec 31, 2019 | 14.38B | 925.00M | 6.88% |
Dec 31, 2018 | 13.45B | 1.18B | 9.61% |
Dec 31, 2017 | 12.27B | 825.10M | 7.21% |
Dec 31, 2016 | 11.45B | 685.00M | 6.36% |
Dec 31, 2015 | 10.76B | 1.06B | 10.93% |
Dec 31, 2014 | 9.70B | 2.77B | 39.97% |
Dec 31, 2013 | 6.93B | 1.42B | 25.66% |
Dec 31, 2012 | 5.52B | 467.83M | 9.27% |
Dec 31, 2011 | 5.05B | 332.21M | 7.04% |
Dec 31, 2010 | 4.72B | 339.08M | 7.75% |
Dec 31, 2009 | 4.38B | 279.84M | 6.83% |
Dec 31, 2008 | 4.10B | 925.89M | 29.19% |
Dec 31, 2007 | 3.17B | 488.57M | 18.21% |
Dec 31, 2006 | 2.68B | 260.55M | 10.76% |
Dec 31, 2005 | 2.42B | 210.94M | 9.54% |
Dec 31, 2004 | 2.21B | 1.53B | 225.62% |
Dec 31, 2003 | 679.18M | 274.96M | 68.02% |
Dec 31, 2002 | 404.22M | 131.55M | 48.24% |
Dec 31, 2001 | 272.68M | 118.00M | 76.28% |
Dec 31, 2000 | 154.68M | 36.68M | 31.08% |
Dec 31, 1999 | 118.00M | 31.04M | 35.70% |
Dec 31, 1998 | 86.96M | 42.35M | 94.95% |
Dec 31, 1997 | 44.61M | 14.60M | 48.64% |
Dec 31, 1996 | 30.01M | 6.37M | 26.96% |
Dec 31, 1995 | 23.64M | 16.19M | 217.56% |
Dec 31, 1994 | 7.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 216.15B |
Humana | 109.24B |
Haleon | 14.31B |
Alcon | 9.46B |
ICON PLC | 8.23B |
Zimmer Biomet Holdings | 7.39B |
ResMed | 4.58B |
Mettler-Toledo International | 3.79B |
BIIB News
- 6 days ago - Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA® - GlobeNewsWire
- 7 days ago - Biogen Stock Rises After Earnings and on Jump in Alzheimer's Drug Sales - Barrons
- 7 days ago - Biogen Q1 2024 results surpass expectation despite revenue decline - Invezz
- 7 days ago - Biogen first-quarter profit tops estimates as Alzheimer's drug uptake improves - Market Watch
- 7 days ago - Biogen beats quarterly profit estimates, Alzheimer's drug sales jump - Reuters
- 7 days ago - Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up - CNBC
- 5 weeks ago - Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease - Business Wire
- 5 weeks ago - EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes - Reuters